Paper501146
Antimicrobial susceptibilities of species of viridans streptococci.
Bourgault AM and 2 others. J Infect Dis, 1979. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. Antimicrobial susceptibilities of species of viridans streptococci. Papers, record 501146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/501146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Streptococcus | Major topic |
| Antibiotics, Antitubercular | |
| Cephalosporins | |
| Dose-Response Relationship, Drug | |
| Gentamicins | |
| Penicillins | |
| Species Specificity | |
| Streptococcus mutans | |
| Streptococcus sanguis |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22346377 | In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study. | Can J Infect Dis | 1999 | https://conductscience.org/library/papers/22346377 | PubMed |
| 20404127 | Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20404127 | PubMed |
| 20195536 | The genome of Streptococcus mitis B6--what is a commensal? | PLoS One | 2010 | https://conductscience.org/library/papers/20195536 | PubMed |
| 18812504 | A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18812504 | PubMed |
| 15504884 | Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15504884 | PubMed |
| 10471583 | In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10471583 | PubMed |
| 9854058 | E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. | J Clin Microbiol | 1999 | https://conductscience.org/library/papers/9854058 | PubMed |
| 9145886 | Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145886 | PubMed |
| 8849246 | Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8849246 | PubMed |
| 8740852 | Prospective study of Streptococcus milleri bacteremia. | Eur J Clin Microbiol Infect Dis | 1996 | https://conductscience.org/library/papers/8740852 | PubMed |
| 6732222 | Infection caused by vancomycin-resistant Streptococcus sanguis II. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6732222 | PubMed |
| 6272080 | Plasmids, drug resistance, and gene transfer in the genus Streptococcus. | Microbiol Rev | 1981 | https://conductscience.org/library/papers/6272080 | PubMed |
| 4073868 | Vancomycin-resistant streptococci or Leuconostoc sp. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4073868 | PubMed |
| 4035635 | Streptococcus milleri as a cause of pleural empyema. | Thorax | 1985 | https://conductscience.org/library/papers/4035635 | PubMed |
| 3800352 | Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3800352 | PubMed |
| 3752979 | Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3752979 | PubMed |
| 3654951 | Meningitis caused by vancomycin-resistant Leuconostoc sp. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3654951 | PubMed |
| 3319505 | In vitro antibacterial effects of cephalosporins. | Drugs | 1987 | https://conductscience.org/library/papers/3319505 | PubMed |
| 3060239 | Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. | Clin Microbiol Rev | 1988 | https://conductscience.org/library/papers/3060239 | PubMed |
| 2729950 | Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2729950 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/501146
GET https://conductscience.org/api/papers/v1/501146/cited_by?page=2